| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |